Mass Spec Alternative Detects Biomarker Signatures in Tissues, Blood, and Cell Culture The current generation of antibody microarray technologies is providing highly sensitive new tools for screening ...

(RTTNews) - Quotient Ltd. (QTNT) reported that an independent study conducted in Madrid, Spain has confirmed the high performance characteristics of the company's MosaiQ COVID-19 Antibody Microarray.

JERSEY, Channel Islands, May 01, 2020 (GLOBE NEWSWIRE) -- Quotient Limited (NASDAQ:QTNT), a commercial-stage diagnostics company (the Company), headquartered in Eysins, Switzerland, today announced ...